Stay away from Cue Biopharma Inc (CUE) Stock or get into it
Jefferies raised the price target for the Cue Biopharma Inc (NASDAQ:CUE) stock to “a Buy”. The rating was released on March 13, 2024, according to finviz. The research report from Piper Sandler has initiated the stock to Overweight, with a price target set at $7. The stock was initiated by H.C. Wainwright, who disclosed in […]
Facts about Cue Biopharma Inc (CUE) Stock that you might not know
Jefferies raised the price target for the Cue Biopharma Inc (NASDAQ:CUE) stock to “a Buy”. The rating was released on March 13, 2024, according to finviz. The research report from Piper Sandler has initiated the stock to Overweight, with a price target set at $7. The stock was initiated by H.C. Wainwright, who disclosed in […]
Offering unique exposure at competitive prices: Cue Biopharma Inc (CUE) Stock
Jefferies raised the price target for the Cue Biopharma Inc (NASDAQ:CUE) stock to “a Buy”. The rating was released on March 13, 2024, according to finviz. The research report from Piper Sandler has initiated the stock to Overweight, with a price target set at $7. The stock was initiated by H.C. Wainwright, who disclosed in […]
